Published in Front Mol Neurosci on January 04, 2017
The Role of the Heat Shock Protein B8 (HSPB8) in Motoneuron Diseases. Front Mol Neurosci (2017) 0.75
Endoplasmic Reticulum Malfunction in the Nervous System. Front Neurosci (2017) 0.75
Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol (2007) 33.06
Quality control in the endoplasmic reticulum. Nat Rev Mol Cell Biol (2003) 9.85
DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell (1991) 7.93
Feedback inhibition of the unfolded protein response by GADD34-mediated dephosphorylation of eIF2alpha. J Cell Biol (2001) 7.82
Decay of endoplasmic reticulum-localized mRNAs during the unfolded protein response. Science (2006) 6.75
The origin and development of glial cells in peripheral nerves. Nat Rev Neurosci (2005) 5.59
Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev (2001) 5.50
Transcriptional induction of mammalian ER quality control proteins is mediated by single or combined action of ATF6alpha and XBP1. Dev Cell (2007) 5.45
XBP1 controls diverse cell type- and condition-specific transcriptional regulatory networks. Mol Cell (2007) 4.93
ER chaperones in mammalian development and human diseases. FEBS Lett (2007) 4.40
In and out of the ER: protein folding, quality control, degradation, and related human diseases. Physiol Rev (2007) 3.51
Targeting the unfolded protein response in disease. Nat Rev Drug Discov (2013) 3.37
Selective inhibition of a regulatory subunit of protein phosphatase 1 restores proteostasis. Science (2011) 3.29
The ER function BiP is a master regulator of ER function. Mt Sinai J Med (2004) 3.01
Ablation of the UPR-mediator CHOP restores motor function and reduces demyelination in Charcot-Marie-Tooth 1B mice. Neuron (2008) 2.95
Calreticulin is essential for cardiac development. J Cell Biol (1999) 2.88
Globoid cell leucodystrophy (Krabbe's disease): deficiency of galactocerebroside beta-galactosidase. Proc Natl Acad Sci U S A (1970) 2.48
Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects. Science (2004) 2.39
The eIF2α kinases: their structures and functions. Cell Mol Life Sci (2013) 2.37
Emerging role for autophagy in the removal of aggresomes in Schwann cells. J Neurosci (2003) 2.21
Identical point mutations of PMP-22 in Trembler-J mouse and Charcot-Marie-Tooth disease type 1A. Nat Genet (1992) 2.04
Proteostasis control by the unfolded protein response. Nat Cell Biol (2015) 1.99
The delicate balance between secreted protein folding and endoplasmic reticulum-associated degradation in human physiology. Physiol Rev (2012) 1.95
Assembly of CNS myelin in the absence of proteolipid protein. Neuron (1997) 1.93
The unfolded protein response modulates disease severity in Pelizaeus-Merzbacher disease. Neuron (2002) 1.91
Mutations in each of the five subunits of translation initiation factor eIF2B can cause leukoencephalopathy with vanishing white matter. Ann Neurol (2002) 1.89
Stress-independent activation of XBP1s and/or ATF6 reveals three functionally diverse ER proteostasis environments. Cell Rep (2013) 1.87
Preventing proteostasis diseases by selective inhibition of a phosphatase regulatory subunit. Science (2015) 1.80
Protein composition of myelin of the peripheral nervous system. J Neurochem (1973) 1.79
Endoplasmic reticulum stress in disorders of myelinating cells. Nat Neurosci (2009) 1.76
Myelination of the nervous system: mechanisms and functions. Annu Rev Cell Dev Biol (2014) 1.69
Role of myelin P0 protein as a homophilic adhesion molecule. Nature (1990) 1.68
Mouse P0 gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axons. Cell (1992) 1.68
Cleaning up in the endoplasmic reticulum: ubiquitin in charge. Nat Struct Mol Biol (2014) 1.66
PMP22 accumulation in aggresomes: implications for CMT1A pathology. Neurobiol Dis (1999) 1.65
The Twitcher mouse: an enzymatically authentic model of human globoid cell leukodystrophy (Krabbe disease). Brain Res (1980) 1.64
Characterization of a novel peripheral nervous system myelin protein (PMP-22/SR13). J Cell Biol (1992) 1.56
Genetics of Charcot-Marie-Tooth (CMT) Disease within the Frame of the Human Genome Project Success. Genes (Basel) (2014) 1.56
Vanishing white matter disease. Lancet Neurol (2006) 1.55
Essential role of the unfolded protein response regulator GRP78/BiP in protection from neuronal apoptosis. Cell Death Differ (2009) 1.55
The PMP22 gene and its related diseases. Mol Neurobiol (2012) 1.53
Intracellular transport, assembly, and degradation of wild-type and disease-linked mutant gap junction proteins. Mol Biol Cell (2000) 1.53
Disrupted proteolipid protein trafficking results in oligodendrocyte apoptosis in an animal model of Pelizaeus-Merzbacher disease. J Cell Biol (1998) 1.53
Regulation of proteasome activity in health and disease. Biochim Biophys Acta (2013) 1.52
Trembler mouse carries a point mutation in a myelin gene. Nature (1992) 1.51
The mammalian endoplasmic reticulum-associated degradation system. Cold Spring Harb Perspect Biol (2013) 1.50
Association of calnexin with mutant peripheral myelin protein-22 ex vivo: a basis for "gain-of-function" ER diseases. Proc Natl Acad Sci U S A (2002) 1.50
A cellular mechanism governing the severity of Pelizaeus-Merzbacher disease. Nat Genet (1996) 1.39
Protein misfolding in the endoplasmic reticulum as a conduit to human disease. Nature (2016) 1.37
A leucine-to-proline mutation in the putative first transmembrane domain of the 22-kDa peripheral myelin protein in the trembler-J mouse. Proc Natl Acad Sci U S A (1992) 1.36
Evidence that the major protein in rat sciatic nerve myelin is a glycoprotein. J Neurochem (1973) 1.34
Different intracellular pathomechanisms produce diverse Myelin Protein Zero neuropathies in transgenic mice. J Neurosci (2006) 1.34
Altered trafficking of mutant connexin32. J Neurosci (1997) 1.33
Protein zero (P0)-deficient mice show myelin degeneration in peripheral nerves characteristic of inherited human neuropathies. Nat Genet (1995) 1.33
Protein zero of peripheral nerve myelin: biosynthesis, membrane insertion, and evidence for homotypic interaction. Neuron (1990) 1.32
Functions and pathologies of BiP and its interaction partners. Cell Mol Life Sci (2009) 1.28
Pelizaeus-Merzbacher disease, Pelizaeus-Merzbacher-like disease 1, and related hypomyelinating disorders. Semin Neurol (2012) 1.27
Protein folding in the endoplasmic reticulum. Cold Spring Harb Perspect Biol (2013) 1.26
Quantitative and integrative proteome analysis of peripheral nerve myelin identifies novel myelin proteins and candidate neuropathy loci. J Neurosci (2011) 1.26
Defective glial maturation in vanishing white matter disease. J Neuropathol Exp Neurol (2011) 1.25
Leukoencephalopathy with vanishing white matter: a review. J Neuropathol Exp Neurol (2010) 1.24
Early postnatal death and motor disorders in mice congenitally deficient in calnexin expression. Mol Cell Biol (2002) 1.22
Krabbe disease: genetic aspects and progress toward therapy. Mol Genet Metab (2000) 1.22
Oligodendrocyte-specific activation of PERK signaling protects mice against experimental autoimmune encephalomyelitis. J Neurosci (2013) 1.22
EIF2B5 mutations compromise GFAP+ astrocyte generation in vanishing white matter leukodystrophy. Nat Med (2005) 1.20
Monoclonal antibody O10 defines a conformationally sensitive cell-surface epitope of proteolipid protein (PLP): evidence that PLP misfolding underlies dysmyelination in mutant mice. J Neurosci (1996) 1.20
Alterations in degradative pathways and protein aggregation in a neuropathy model based on PMP22 overexpression. Neurobiol Dis (2005) 1.20
Role of calnexin in the glycan-independent quality control of proteolipid protein. EMBO J (2003) 1.19
Neurons promote the translocation of peripheral myelin protein 22 into myelin. J Neurosci (1997) 1.18
Oral curcumin mitigates the clinical and neuropathologic phenotype of the Trembler-J mouse: a potential therapy for inherited neuropathy. Am J Hum Genet (2007) 1.18
Immunocytochemical localization of P0 protein in Golgi complex membranes and myelin of developing rat Schwann cells. J Cell Biol (1981) 1.18
Deletion of the serine 34 codon from the major peripheral myelin protein P0 gene in Charcot-Marie-Tooth disease type 1B. Nat Genet (1993) 1.17
Aggresome formation in neuropathy models based on peripheral myelin protein 22 mutations. Neurobiol Dis (2002) 1.15
The unfolded protein response in vanishing white matter disease. J Neuropathol Exp Neurol (2005) 1.13
The formation of peripheral myelin protein 22 aggregates is hindered by the enhancement of autophagy and expression of cytoplasmic chaperones. Neurobiol Dis (2006) 1.13
Peripheral neuropathies caused by mutations in the myelin protein zero. J Neurol Sci (2006) 1.13
Resetting translational homeostasis restores myelination in Charcot-Marie-Tooth disease type 1B mice. J Exp Med (2013) 1.13
Heightened stress response in primary fibroblasts expressing mutant eIF2B genes from CACH/VWM leukodystrophy patients. Hum Genet (2005) 1.12
Diverse trafficking abnormalities of connexin32 mutants causing CMTX. Neurobiol Dis (2002) 1.12
A common mechanism of PLP/DM20 misfolding causes cysteine-mediated endoplasmic reticulum retention in oligodendrocytes and Pelizaeus-Merzbacher disease. Proc Natl Acad Sci U S A (2007) 1.12
Proteolipid protein is necessary in peripheral as well as central myelin. Neuron (1997) 1.11
Decreased guanine nucleotide exchange factor activity in eIF2B-mutated patients. Eur J Hum Genet (2004) 1.11
Curcumin treatment abrogates endoplasmic reticulum retention and aggregation-induced apoptosis associated with neuropathy-causing myelin protein zero-truncating mutants. Am J Hum Genet (2005) 1.11
PMP22 carrying the trembler or trembler-J mutation is intracellularly retained in myelinating Schwann cells. Neurobiol Dis (2000) 1.10
CHOP and the endoplasmic reticulum stress response in myelinating glia. Curr Opin Neurobiol (2009) 1.07
Impaired proteasome activity and accumulation of ubiquitinated substrates in a hereditary neuropathy model. J Neurochem (2005) 1.07
A mouse model for eukaryotic translation initiation factor 2B-leucodystrophy reveals abnormal development of brain white matter. Brain (2010) 1.07
Molecular characterization of mutations that cause globoid cell leukodystrophy and pharmacological rescue using small molecule chemical chaperones. J Neurosci (2010) 1.07
Overloaded endoplasmic reticulum-Golgi compartments, a possible pathomechanism of peripheral neuropathies caused by mutations of the peripheral myelin protein PMP22. J Neurosci (1998) 1.06
Different cellular and molecular mechanisms for early and late-onset myelin protein zero mutations. Hum Mol Genet (2008) 1.06
Perturbed interactions of mutant proteolipid protein/DM20 with cholesterol and lipid rafts in oligodendroglia: implications for dysmyelination in spastic paraplegia. J Neurosci (2006) 1.05
Dynamics and mechanisms of CNS myelination. Dev Cell (2015) 1.05
Detection and processing of peripheral myelin protein PMP22 in cultured Schwann cells. J Biol Chem (1993) 1.05
Curcumin derivatives promote Schwann cell differentiation and improve neuropathy in R98C CMT1B mice. Brain (2012) 1.05
Pharmacological Chaperone Therapy: Preclinical Development, Clinical Translation, and Prospects for the Treatment of Lysosomal Storage Disorders. Mol Ther (2015) 1.04
Effect of an R69C mutation in the myelin protein zero gene on myelination and ion channel subtypes. Arch Neurol (2006) 1.04
MpzR98C arrests Schwann cell development in a mouse model of early-onset Charcot-Marie-Tooth disease type 1B. Brain (2012) 1.04
Glycosylation-directed quality control of protein folding. Nat Rev Mol Cell Biol (2015) 1.04
Role of the unfolded protein response, GRP78 and GRP94 in organ homeostasis. J Cell Physiol (2015) 1.04
The unfolded protein response triggers selective mRNA release from the endoplasmic reticulum. Cell (2014) 1.02